澳瑞他汀 F
Auristatin F 是抗体偶联活性分子中一种有效的细胞毒素 (cytotoxin),也是 MMAF 的类似物。Auristatin F 是一种有效的微管 (microtubule) 抑制剂和血管损伤剂 (VDA)。Auristatin F 通过阻止微管蛋白聚集抑制细胞分裂。Auristatin F 可用于抗体-活性分子偶联物 (ADC)。
Auristatin F-d8 是氘代标记的 Auristatin F (HY-15583)。Auristatin F 是抗体偶联活性分子中一种有效的细胞毒素 (cytotoxin),也是 MMAF 的类似物。Auristatin F 是一种有效的微管 (microtubule) 抑制剂和血管损伤剂 (VDA)。Auristatin F 通过阻止微管蛋白聚集抑制细胞分裂。Auristatin F 可用于抗体-活性分子偶联物 (ADC)。
Tubulysin A intermediate-1 是合成细胞毒性肽 Tubulysin A (HY-15995) 的中间体。Tubulysin A (TubA) 是一种抗生素 (antibiotic)、抗微管毒素 (anti-microtubule toxins),和细胞凋亡 (apoptosis) 诱导剂,能够从粘细菌中分离得到。Tubulysin A 具有抗血管生成、抗微管、抗有丝分裂、和抗增殖活性。Tubulysin A 能够将细胞阻滞在 G2/M 期,有效地抑制微管蛋白聚合,并诱导分离的微管解聚。Tubulysin A 可作为 ADC 细胞毒素 (ADC Cytotoxin) 合成 ADC。
微管蛋白抑制剂 B
Tubulysin B 是一种高度细胞毒性的肽,有效的微管去稳定剂,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。Tubulysin B 抑制许多癌细胞系,包括具有多药抗性的细胞系,IC50 值在皮纳摩尔范围内。Tubulysin B 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
微管蛋白抑制剂 B
Tubulysin B 是一种高度细胞毒性的肽,有效的微管去稳定剂,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。Tubulysin B 抑制许多癌细胞系,包括具有多药抗性的细胞系,IC50 值在皮纳摩尔范围内。Tubulysin B 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
微管相关蛋白 tau (MAPT) 在促进微管组装和稳定性方面发挥着关键作用,表明其对神经元极性建立的潜在贡献。C 末端与轴突微管结合,而 N 末端与神经质膜成分相互作用,充当这些结构之间的关键连接蛋白。Microtubule-associated protein tau Protein, Mouse (P.pastoris, His) 是重组的 微管相关蛋白 tau 蛋白,由 P. pastoris 表达,带有 N-6*His 标签。Microtubule-associated protein tau Protein, Mouse (P.pastoris, His) 全长 732 个氨基酸,分子量约为 ~78.1 kDa。
微管相关蛋白 tau (MAPT) 关键促进微管组装和稳定性,通过作为重要的连接蛋白影响神经元极性。其双重作用涉及 C 端与轴突微管的结合和 N 端与神经质膜成分的结合。Microtubule-associated protein tau Protein, Rat (P.pastoris, His) 是重组的 微管相关蛋白 tau 蛋白,由 P. pastoris 表达,带有 N-His 标签。Microtubule-associated protein tau Protein, Rat (P.pastoris, His) 全长 751 个氨基酸,分子量约为 ~80.4 kDa。
Microtubule-associated protein tau 是一种大量存在于中枢神经系统 (CNS) 神经元中的微管相关蛋白。MAPT 促进微管组装和稳定性,并可能参与神经元极性的建立和维持。MAPT 的过表达与前列腺癌的不良预后相关。MAPT 与神经性疾病如阿尔茨海默病和帕金森病有关。Tau-F/MAPT Protein, Human 是重组的 Tau-F/MAPT 蛋白,由 E. coli 表达,不带标签。Tau-F/MAPT Protein, Human 全长 441 个氨基酸,分子量约为 ~60.0 kDa。
MARK4 是一种关键的丝氨酸/苏氨酸蛋白激酶,对细胞过程具有至关重要的影响。它磷酸化微管相关蛋白(MAPT/TAU、MAP2、MAP4)并重组微管网络。MARK4 Protein, Human 是重组的 MARK4 蛋白,由 E. coli 表达,不带标签。MARK4 Protein, Human 全长 327 个氨基酸。
MARK1 是一种重要的丝氨酸/苏氨酸蛋白激酶,可严格调节细胞极性和微管动力学。它磷酸化微管相关蛋白(DCX、MAP2、MAP4、MAPT/TAU),导致其解离和分解。MARK1 Protein, Human 是重组的 MARK1 蛋白,由 E. coli 表达,不带标签。MARK1 Protein, Human 全长 751 个氨基酸。
Auristatin F-d8 是氘代标记的 Auristatin F (HY-15583)。Auristatin F 是抗体偶联活性分子中一种有效的细胞毒素 (cytotoxin),也是 MMAF 的类似物。Auristatin F 是一种有效的微管 (microtubule) 抑制剂和血管损伤剂 (VDA)。Auristatin F 通过阻止微管蛋白聚集抑制细胞分裂。Auristatin F 可用于抗体-活性分子偶联物 (ADC)。
microtubule associated protein 2; MAP2A; MAP2B; MAP2C
WB, IF-Cell, IHC-P
Human, Mouse, Rat
MAP2 Antibody is an unconjugated, approximately 60 kDa, rabbit-derived, anti-MAP2 polyclonal antibody. MAP2 Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.
Tau Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Tau. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Phospho-Tau (Ser198) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser198). It can be used for WB,IP assays with tag free, in the background of Human.
Phospho-Tau (Ser404) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser404). It can be used for WB assays with tag free, in the background of Human, Rat.
Phospho-Tau (Thr181) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Thr181). It can be used for WB,IP assays with tag free, in the background of Human.
LC3 Antibody is an unconjugated, approximately 14/16 kDa, rabbit-derived, anti-LC3 polyclonal antibody. LC3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, chicken, dog, pig, cow, horse, sheep, goat background without labeling.
ERK1 + ERK2 (phospho Thr183/Tyr185); phospho-ERK1/MAPK-1/2(Thr183/Tyr185); ERK 1; ERK 2; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK1; MAPK2; MGC20180; microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_MOUSE; p38; p40; p41; p41mapk; p42 MAPK; p42-MAPK; p42MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44ERK1; p44MAPK; p44MAPK; PRKM 1; PRKM 1; PRKM 2; PRKM 2; PRKM1; PRKM2; Protein kinase mitogen activated 1; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 2; Protein tyrosine kinas.
WB; ELISA; IHC-P; IHC-F; ICC; IF
Human, Mouse(predicted: Rat, Chicken, Dog, Cow, Horse, Rabbit, Guinea Pig)
phospho-ERK1 + 2 (Thr183/Tyr185) Antibody is an unconjugated, approximately 42/44 kDa, rabbit-derived, anti-phospho-ERK1 + 2 (Thr183/Tyr185) polyclonal antibody. phospho-ERK1 + 2 (Thr183/Tyr185) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, cow, horse, rabbit, guinea pig background without labeling.
B cell antigen receptor Ig beta associated protein 1; BPM 90; BPM L; BPM-L; BPM90; BPML; IBAP 1; Imp 9; Importin 9; Novel centrosomal protein RanBPM; RAN binding protein 9; Ran binding protein centrosomal; Ran Binding Protein in the microtubule organizing center; Ran binding protein M; Ran BP9; Ran-binding protein 9; Ran-binding protein M; RANB9_HUMAN; RanBP 7; RANBP 9; RanBP7; RanBP9; RanBPM.